- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03399877
A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography
January 14, 2019 updated by: Yonsei University
Uroflowmetry(UF) has been the standard first-line diagnostic tool for the evaluation of pediatric voiding dysfunction.
But recently, UF combined with pelvic flow electromyography(EMG) is emphasized and recommended to analyze the separate contributions of the detrusor and bladder outlet and sole UF is discouraged except for the follow-up study after abnormal UF/EMG result(Bauer et al., 2015).
However, electrode itself can disturb pelvic floor relaxation and there is no evidence about necessity of consecutive UF/EMG test.
Therefore, the investigators are going to compare three different methods (Primary-Secondary: UF/EMG-UF/EMG, UF/EMG-sole UF, sole UF-UF/EMG)
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 03722
- Recruiting
- Department of Urology,
-
Contact:
- Yong Seung Lee, MD
- Phone Number: 82-2-2228-2310
- Email: asforthelord@yuhs.ac
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
1) children aged 5 to 11.9 who visit pediatric urology department for enuresis.
Exclusion Criteria:
- If children have experience of performing uroflowmetry or uroflowmetry-electromyography.
- If children do not cooperate on performing the test
- If enuresis is caused by neurological or anatomical problem.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Combining electromygraphy with uroflowmetry
Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography
|
Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography again.
|
Active Comparator: Uroflowmetry
Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform uroflowmetry solely.
|
Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform sole uroflowmetry.
|
Experimental: Uroflowmetry-Combining electromygraphy with uroflowmetry
Children who assigned Group C firstly perform uroflowmetry solely.
and subsequently perform uroflowmetry-electromyography.
|
Children who assigned Group C firstly perform sole uroflowmetry and subsequently perform uroflowmetry-electromyography.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
maximum flow rate(Qmax=cc/s)
Time Frame: One day
|
The maximum flow rate is the most important uroflowmetry index to diagnose bladder outlet obstruction or bladder contractility.
|
One day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Uroflow curve pattern
Time Frame: One day
|
Uroflow curve pattern: There are 5 uroflow curve patterns, bell-shaped, tower-shaped, interrupted-shaped, staccato-shaped and plateau shaped by uroflowmetry.
The shape is determined by detrusor contractility and influenced by abdominal straining, coordination with the bladder outlet musculature and any distal anatomic obstruction.
|
One day
|
post void residual
Time Frame: One day
|
post-void residual(cc): ultrasonographic bladder scan machines calculates bladder volume.
PVR measurements in neurologically intact children are highly variable.
PVR must be obtained immediately after voiding(<5min)
|
One day
|
synergy or dyssynergy between the bladder and the pelvic floor.
Time Frame: One day
|
synergy or dyssynergy between the bladder and the pelvic floor is abstained by combining electromyography with uroflowmetry.
|
One day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 4, 2017
Primary Completion (Anticipated)
October 1, 2019
Study Completion (Anticipated)
October 1, 2019
Study Registration Dates
First Submitted
December 22, 2017
First Submitted That Met QC Criteria
January 8, 2018
First Posted (Actual)
January 17, 2018
Study Record Updates
Last Update Posted (Actual)
January 16, 2019
Last Update Submitted That Met QC Criteria
January 14, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2017-0842
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Enuresis
-
Rabin Medical CenterUnknownMonosymptomatic Enuresis NocturnaIsrael
-
University GhentCompletedMonosymptomatic Nocturnal EnuresisBelgium
-
University Hospital, GhentFerring PharmaceuticalsCompletedMonosymptomatic Nocturnal EnuresisBelgium
-
Lancashire Teaching Hospitals NHS Foundation TrustUniversity of Central LancashireCompletedEnuresis | Enuresis, NocturnalUnited Kingdom
-
Children's Hospital of Fudan UniversityCompleted
-
Gina LockwoodPottyMDRecruiting
-
Ferring PharmaceuticalsCompleted
-
Cairo UniversityUnknownPrimary Monosymptomatic Nocturnal EnuresisEgypt
-
Fr Muller Homoeopathic Medical CollegeFather Muller Medical CollegeUnknownBed Wetting | Primary EnuresisIndia
-
Ferring PharmaceuticalsCompleted
Clinical Trials on Combining electromyography with uroflowmetry (group A)
-
Universitat Jaume IRecruiting
-
University of California, San FranciscoWithdrawn
-
Wake Forest University Health SciencesNational Center for Complementary and Integrative Health (NCCIH)Not yet recruiting
-
University of Sao PauloFederal University of São PauloRecruitingRenal Insufficiency, ChronicBrazil
-
Selcuk UniversityRecruitingHospitalization | Feeding Patterns | Breast Feeding, ExclusiveTurkey
-
Lawson Health Research InstituteCompleted
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; UHasseltActive, not recruitingLow Back Pain, Recurrent | Surgery | Physical DisabilityBelgium
-
Mahitab Mohammed Yosri IbrahimCompletedPolycystic Ovary Syndrome
-
ResMedCompleted